Viewing data from:

OXYCODONE HYDROCHLORIDE

ANDA

OXYCODONE HYDROCHLORIDE | A202116 | ALVOGEN INC

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: ROXICODONE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 6 NDCs

Highest NADAC/Unit

$0.3612

per ea

Lowest NADAC/Unit

$0.0924

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
47781026501OXYCODONE HCL (IR) 30 MG TAB	$0.3612	EA	Generic	—	2026-10-21
47781026505OXYCODONE HCL (IR) 30 MG TAB	$0.3612	EA	Generic	—	2026-10-21
47781026401OXYCODONE HCL (IR) 15 MG TAB	$0.1993	EA	Generic	—	2026-10-21
47781026405OXYCODONE HCL (IR) 15 MG TAB	$0.1993	EA	Generic	—	2026-10-21
47781026301OXYCODONE HCL (IR) 5 MG TABLET	$0.0924	EA	Generic	—	2026-10-21
47781026305OXYCODONE HCL (IR) 5 MG TABLET	$0.0924	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain6 active DMFs6 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

SPECGX LLCOXYCODONE HYDROCHLORIDE USP (D)

DMF 69301987

NORAMCO LLCOXYCODONE HYDROCHLORIDE

DMF 163992003

VERANOVA LPOXYCODONE HYDROCHLORIDE

DMF 184722005

NORAMCO LLCOXYCODONE HYDROCHLORIDE DRUG SUBSTANCE

DMF 209752007

CHATTEM CHEMICALS INCOXYCODONE HYDROCHLORIDE, USP

DMF 234192010

SIEGFRIED USA LLCOXYCODONE HYDROCHLORIDE USP

DMF 235202010

MALLINCKRODT CHEMICAL INCInactiveOXYCODONE HYDROCHLORIDE PURIFIED RECRYSTALLIZED

DMF 28211977

NORAMCO INCInactiveOXYCODONE HYDROCHLORIDE

DMF 63181986

PENICK CORPInactiveOXYCODONE HYDROCHLORIDE

DMF 67681987

SIEGFRIED USA INCInactiveOXYCODONE HYDROCHLORIDE USP

DMF 193962006

JOHNSON MATTHEY PHARMACEUTICAL MATERIALSInactiveOXYCODONE HYDROCHLORIDE (MS PROCESS)

DMF 207292007

NORAMCO LLCInactiveOXYCODONE HYDROCHLORIDE USP (PROCESS II)

DMF 313772018

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#001 — 5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 30, 2011

No patent or exclusivity listings for this strength.

#002 — 15MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 30, 2011

#003 — 30MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 30, 2011